Recent Blog Posts

View Post: ANTI-CANCER
2 Dec 2009
GOSERELIN 3. NAFERELIN H. AROMATASE INHIBITORS 1. AMINOGLUTETHIMIDE & TRILOSTANE 2. ANASTROZOLE 3. LETROZOLE 4.EXEMESTANE Slide 23: MISCELLANEOUS ANTI - CANCER DRUGS 1. ASPARAGINASE (CRISANTASPASE) 2. HYDROXYUREA 3. MITOTANE 4. ...
View Blog: Recent plicks from myplick.com - http://www.myplick.com/

---

View Post: Management of Endocrine Manifestations and the Use of Mitotane As ...
21 Sep 2009 by Veytsman, Nieman, Fojo  
Management of Endocrine Manifestations and the Use of Mitotane As a Chemotherapeutic Agent for Adrenocortical Carcinoma. Irina Veytsman, Lynnette Nieman, Tito Fojo. From the Medical Oncology Branch, Center for Cancer Research, ...
View Blog: Journal of Clinical Oncology Current Issue - http://jco.ascopubs.org/

---

View Post: MCI SEPT 2009 MEDICINE
1 Dec 2009 by deepakmarwah  
b. mitotane c. Meta-pyrone d. mirapex a.Aminoglutethimide is an anti-steroid drug, It blocks the production of steroids derived from cholesterol and is clinically used in the treatment of Cushing's syndrome and metastatic breast cancer. ...
View Blog: fmgee - http://fmgee.blogspot.com/

---

View Post: OSI-906 In Clinical Trial For Adrenocortical Carci
4 Nov 2009 by psoriasis8  
TGen Clinical Research Services at Scottsdale Healthcare have announced the start of a clinical trial for a drug designed to combat adrenocortical carcinoma (ACC), a rare but deadly cancer that attacks the adrenal glands. ...
View Blog: The - http://psoriasis8.fidelityaccount.org/

---

View Post: New Drug May Offer Hope for Adrenocortical Carcinoma Patients
3 Oct 2009 by Standplaats: Amerika  
TGen Clinical Research Services (TCRS) at Scottsdale Healthcare in Scottsdale, Arizona, recently announced the start of a clinical trial for a drug designed to combat adrenocortical carcinoma (ACC), a rare but deadly cancer that forms ...
View Blog: Onco'Zine - The International Cancer Blog - http://oncozine.blogspot.com/

---

View Post: Breakthrough drug could be new hope for adrenal cancer patients
23 Sep 2009 by admin  
Other than surgery, the only treatment for ACC is the exacting use of a compound called mitotane, a chemical relative of DDT, which the US banned as an insecticide in 1972. TCRS clinicians hope the new compound, OSI-906, developed by ...
View Blog: BreakThrough Digest Medical News - http://www.breakthroughdigest.com/

---

View Post: adrenal cancer page 3
26 Jul 2009 by CANCER  
the most common chemotherapy used in treatment of adrenal cortical cancers is mitotane. mitotane acts to block the hormones produced by the cancer and can also kill adrenal cancer cells. mitotane or other chemotherapy is almost always ...
View Blog: CANCER - http://badcancer.blogspot.com/

---

View Post: TGen News - Revolutionary drug could be new hope for adrenal ...
22 Sep 2009 by news@tgen.org  
22, 2009 – TGen Clinical Research Services at Scottsdale Healthcare today announced the start of a clinical trial for a drug designed to combat adrenocortical carcinoma (ACC), a rare but deadly cancer that attacks the adrenal glands. ... While use of mitotane in ACC patients reduces tumors, it also diminishes adrenal gland function, requiring patients to take hormone replacements for the rest of their lives. In addition, mitotane must be administered for at least three ...
View Blog: TGen News - http://www.tgen.org/news/index.cfm?pageid=1183

---

View Post: adjuvant mitotane for adrenocortical cancer--working through ...
6 Jun 2009
terzolo m, fassnacht m, ciccone g, et al. adjuvant mitotane for adrenocortical cancer--working through uncertainty. [comment, journal article] j clin endocrinol metab 2009 jun; 94(6):1879-80. full citation ...
View Blog: find

---

View Post: how is adrenal cancer treated?
5 Aug 2009 by OBAT KANKER  
a drug called mitotane is most often used to treat people with adrenal cancer. mitotane blocks the gland from making hormones and also destroys cancer cells. studies have shown that starting mitotane treatment when all of the cancer is ...
View Blog: OBAT KANKER - http://obatkankers.blogspot.com/

---